Open0.565 | Close- |
Vol / Avg.1.274K / 3.098K | Mkt Cap10.543M |
Day Range0.565 - 0.890 | 52 Wk Range0.650 - 3.750 |
Ayala Pharmaceuticals Stock (OTC: ADXS) stock price, news, charts, stock research, profile.
Open0.565 | Close- |
Vol / Avg.1.274K / 3.098K | Mkt Cap10.543M |
Day Range0.565 - 0.890 | 52 Wk Range0.650 - 3.750 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-11-16 | Ladenburg Thalmann | Ahu Demir | Downgrades | BuyNeutral | - | - | - |
2023-05-30 | Ladenburg Thalmann | Ahu Demir | Upgrades | NeutralBuy | Announces | - | 4.00 |
2018-12-18 | HC Wainwright & Co. | Swayampakula Ramakanth | Downgrades | BuyNeutral | - | - | - |
2018-06-13 | Jefferies | Biren Amin | Downgrades | BuyHold | Lowers | 9.00 | 2.00 |
You can purchase shares of Ayala Pharmaceuticals (OTCQX: ADXS) through any online brokerage.
There are no as such competitors for Ayala Pharmaceuticals.
The latest price target for Ayala Pharmaceuticals (OTCQX: ADXS) was reported by Ladenburg Thalmann on Thursday, November 16, 2023. The analyst firm set a price target for 0.00 expecting ADXS to fall to within 12 months (a possible -100.00% downside). 2 analyst firms have reported ratings in the last year.
The stock price for Ayala Pharmaceuticals (OTCQX: ADXS) is $0.89 last updated Today at December 5, 2023 at 2:49 PM UTC.
There is no dividend information for Ayala Pharmaceuticals.
Ayala Pharmaceuticals’s Q4 earnings are confirmed for Friday, February 9, 2024.
There is no upcoming split for Ayala Pharmaceuticals.
Ayala Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the OTCQX.